COVID-19 Vaccine: Critical Questions with Complicated Answers

被引:32
作者
Haidere, Mohammad Faisal [1 ]
Ratan, Zubair Ahmed [2 ,3 ]
Nowroz, Senjuti [4 ]
Bin Zaman, Sojib [5 ]
Jung, You-Jung [6 ]
Hosseinzadeh, Hassan [2 ]
Cho, Jae Youl [7 ,8 ]
机构
[1] Univ Dhaka, Dept Soil Water & Environm, Dhaka 1000, Bangladesh
[2] Univ Wollongong, Sch Hlth & Soc, Wollongong, NSW 2500, Australia
[3] Khulna Univ Engn & Technol, Dept Biomed Engn, Khulna 9203, Bangladesh
[4] Univ Dhaka, Dept Chem, Dhaka 1000, Bangladesh
[5] Monash Univ, Sch Clin Sci, Dept Med, Clayton, Vic 3800, Australia
[6] Natl Inst Biol Resources, Biol Resources Utilizat Dept, Incheon 22689, South Korea
[7] Sungkyunkwan Univ, Dept Integrat Biotechnol, Suwon 16419, South Korea
[8] Sungkyunkwan Univ, Biomed Inst Convergence SKKU BICS, Suwon 16419, South Korea
基金
新加坡国家研究基金会;
关键词
COVID-19; Vaccine; Vaccine backfires; Vaccine safety; ANGIOTENSIN-CONVERTING ENZYME; HEPATITIS; IMMUNIZATION; INFECTION;
D O I
10.4062/biomolther.2020.178
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
COVID-19 has caused extensive human casualties with significant economic impacts around the globe, and has imposed new challenges on health systems worldwide. Over the past decade, SARS, Ebola, and Zika also led to significant concerns among the scientific community. Interestingly, the SARS and Zika epidemics ended before vaccine development; however, the scholarly community and the pharmaceutical companies responded very quickly at that time. Similarly, when the genetic sequence of SARS-CoV-2 was revealed, global vaccine companies and scientists have stepped forward to develop a vaccine, triggering a race toward vaccine development that the whole world is relying on. Similarly, an effective and safe vaccine could play a pivotal role in eradicating COVID-19. However, few important questions regarding SARS-CoV-2 vaccine development are explored in this review.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 64 条
  • [1] Adams Emily R, 2020, Wellcome Open Res, V5, P139, DOI 10.12688/wellcomeopenres.15927.1
  • [2] The proximal origin of SARS-CoV-2
    Andersen, Kristian G.
    Rambaut, Andrew
    Lipkin, W. Ian
    Holmes, Edward C.
    Garry, Robert F.
    [J]. NATURE MEDICINE, 2020, 26 (04) : 450 - 452
  • [3] Andrews Sophie M, 2017, F1000Res, V6, P597, DOI 10.12688/f1000research.10876.1
  • [4] [Anonymous], 2021, Weekly epidemiological update on COVID-19 - 27 July 2021, V46th
  • [5] Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development
    Arshadi, Arash Keshavarzi
    Webb, Julia
    Salem, Milad
    Cruz, Emmanuel
    Calad-Thomson, Stacie
    Ghadirian, Niloofar
    Collins, Jennifer
    Diez-Cecilia, Elena
    Kelly, Brendan
    Goodarzi, Hani
    Yuan, Jiann Shiun
    [J]. FRONTIERS IN ARTIFICIAL INTELLIGENCE, 2020, 3
  • [6] Hepatitis B vaccination and the risk of multiple sclerosis
    Ascherio, A
    Zhang, SM
    Hernán, MA
    Olek, MJ
    Coplan, PM
    Brodovicz, K
    Walker, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05) : 327 - 332
  • [7] Angiotensin-converting enzyme in innate and adaptive immunity
    Bernstein, Kenneth E.
    Khan, Zakir
    Giani, Jorge F.
    Cao, Duo-Yao
    Bernstein, Ellen A.
    Shen, Xiao Z.
    [J]. NATURE REVIEWS NEPHROLOGY, 2018, 14 (05) : 325 - 336
  • [8] Emerging Concepts and Technologies in Vaccine Development
    Brisse, Morgan
    Vrba, Sophia M.
    Kirk, Natalie
    Liang, Yuying
    Ly, Hinh
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [9] THE TIME COURSE OF THE IMMUNE-RESPONSE TO EXPERIMENTAL CORONAVIRUS INFECTION OF MAN
    CALLOW, KA
    PARRY, HF
    SERGEANT, M
    TYRRELL, DAJ
    [J]. EPIDEMIOLOGY AND INFECTION, 1990, 105 (02) : 435 - 446
  • [10] Fundamentals of Vaccine Immunology
    Clem, Angela S.
    [J]. JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2011, 3 (01) : 73 - 78